
Automation, decentralization and the future of CAR-Ts: Advancements in cell & gene therapy manufacturing (Part III)
The Top Line
00:00
Maximizing Efficiency and Cost-Effectiveness in Cell and Gene Therapy Manufacturing
Exploring the crucial collaboration between technology providers and manufacturers in the cell and gene therapy field to streamline production processes and reduce costs, emphasizing early engagement for optimal efficiency and savings.
Transcript
Play full episode